Hypercapnia has been utilized as a stimulus to elicit changes in cerebral blood flow (CBF). However, in many instances it has been delivered in a non-controlled method that is often difficult to reproduce. The purpose of this study was to examine the within-and between-visit reproducibility of blood oxygen leveldependent (BOLD) signal changes to an iso-oxic square wave alteration in endtidal carbon dioxide partial pressure (P et CO 2 ). Two 3-Tesla (3T) MRI scans were performed on the same visit, with two square wave alterations administered per scan. The protocol was repeated on a separate visit with minimum of 3 days between scanning sessions. P et CO 2 was altered to stimulate changes in cerebral vascular reactivity (CVR), while P et O 2 was held constant. Eleven subjects (six females; mean age 26Á5 AE 5Á7 years) completed the full testing protocol. Excellent within-visit square wave reproducibility (ICC > 0Á75) was observed. Similarly, square waves were reproducible between scanning sessions (ICC > 0Á7). This study demonstrates BOLD signal changes in response to alterations in P et CO 2 are reproducible both within-and between-visit MRI scans.
Introduction
Cerebrovascular reactivity (CVR) is defined as a change in cerebral blood flow due to a vasodilatory stimulus (Schwertfeger et al., 2006) . Impairment in CVR has been observed in a number of cerebral disease processes, such as traumatic brain injury (Len & Neary, 2010) , moyamoya vasculopathy (Han et al., 2011) and seizures (Fierstra et al., 2011) . While a number of different vasodilatory stimuli such as acetazolamide (Asghar et al., 2011) , inhalation of fixed concentrations of carbon dioxide (CO 2 ) (Prisman et al., 2008) and breath holding (Murphy et al., 2011) have been used to induce cerebral vasodilation, these vasodilatory stimuli are not without issues that ultimately limit their use.
The development of a computer-controlled sequential rebreathing device (RespirAct TM ; Thornhill Research, Inc. Toronto, Canada) has enabled researchers to deliver a controlled CO 2 stimulus while concurrently maintaining end-tidal oxygen volumes (P et O 2 ) (Slessarev et al., 2007; Prisman et al., 2008; Mark et al., 2010; Mutch et al., 2012) . Coupling this vasodilatory stimulus with blood oxygen level-dependent (BOLD) magnetic resonance imaging (MRI) is being used more frequently to measure CVR (Spano et al., 2013) due to its availability in clinical settings, larger signal-to-noise ratio as well as its less dependence on mean arterial pressure (MAP) (Halani et al., 2015) compared to arterial spin labelling (ASL). However, to date no studies have specifically explored the within-and between-day reproducibility of this methodology to measure grey matter CVR. Mark et al. (2010) compared computer-controlled prospective end-tidal targeting to traditional manual techniques; however, the authors failed to report neither the quantified values nor the between-day reproducibility. Kassner et al. (2010) described the reproducibility of BOLD CVR using P et CO 2 ; however, the method used by the authors did not clamp P et O 2 when creating hypercapnia. Thus, it is not possible to decouple the effects of PCO 2 from the effects of PO 2 changes on BOLD CVR. Therefore, there is an important gap in the literature relating to using BOLD CVR as a reliable method in research as well as a future clinical tool. The purpose of this study was to examine the reproducibility of grey matter CVR under hypercapnic, iso-oxic conditions.
Subjects and methods
Eleven subjects (five males, six females) between the ages of 18 and 40 years were recruited and submitted written informed consent in compliance with all guidelines set by the University of Minnesota Institutional Review Board and the Health Insurance Portability and Accountability Act (HIPAA). All subjects were free of neurologic disorders and fasted and abstain from caffeine consumption for 12 h, as well as refrain from vigorous exercise for 24 h prior to each scan.
Prior to the MRI studies, subjects were fitted with a specialized rebreathing circuit connected to a custom gas blender (RespirAct TM ), which was utilized to manipulate and analyse P et CO 2 and P et O 2 values. Subjects were instructed to synchronize their breathing rate to 12 breaths/min. P et O 2 values were targeted to 100 mmHg throughout the protocol. Baseline flow and P et CO 2 values were established, and two square wave alterations (+10 mmHg above baseline) were performed during the 30-min familiarization period. Once the initial testing session was successfully completed, subjects were scheduled for full MRI protocol visits. The study protocol consisted of two MRI scans performed on the same visit, with two square wave alterations, similar to the initial session, administered per scan (four squares per visit). The protocol was then repeated on a separate visit with minimum of 3 days between visits.
All imaging were performed at the CMRR at the University of Minnesota with the Siemens (Erlangen, Germany) 3-Tesla Connectome Skyra, a MRI scanner specially modified for the Human Connectome Project (http://humanconnectome.org/). A 32-channel receive-only matrix head coil was used during acquisition. The MRI protocol included short localizer scans to allow for scan prescription, a high-resolution T 1 -weighted scan used for tissue segmentation (TR = 2530 ms, TE = 3Á52 ms, TI = 1100 ms, flip angle = 7°, voxel = 1 mm isotropic, grappa = 2 4 min), a field map scan used to correct the BOLD data for susceptibility-induced geometric distortions (TR = 300 ms, TE = 2Á79 and 5Á25 ms, flip angle = 50°, voxel = 3Á4 9 3Á4 9 4 mm, 39 s) and two long BOLD EPI scans (TR = 2000 ms, TE = 30 ms, flip angle = 77°, voxel = 3Á4 9 3Á4 9 4 mm, 840 volumes, 28 min/scan) used to compute CVR.
Image processing was performed using tools from the FSL toolkit (BET, FLIRT, FEAT, FAST, http://fsl.fmrib.ox.ac.uk/fsl/ fslwiki/). Processing of the high-resolution T1-weighted imaging consisted of brain extraction using BET and a 3-compartment tissue segmentation, using FAST. Preprocessing of the BOLD imaging was conducted within FEAT and included brain extraction, correction for magnetic field induced geometric distortion (using the separately acquired field map) and slice timing correction. No temporal or spatial smoothing was applied to the data. The extracted brain from the T1 scan was aligned to the distortion corrected mean BOLD image, using FLIRT. The grey matter partial volume estimate (PVE) map from the T1 segmentation was aligned to the BOLD data using the same transform, and a grey matter mask was created in BOLD space by thresholding the aligned PVE map at a 50% partial volume estimate. The grey matter BOLD signal, which is the mean voxel intensity within the grey matter mask per time point, was then computed.
Mean CVR in grey matter was computed from the measured P et CO 2 and grey matter BOLD time courses. First, a linear detrend was applied to both the BOLD and P et CO 2 waveforms to remove the effects of scanner drift from the BOLD time course and any linear drift in baseline P et CO 2 . Next, the P et CO 2 waveform was recalculated from the measured values at each point of exhale to represent a sample every 2 seconds using spline interpolation within MATLAB (version 7Á9Á0, Natick, MA). Timing differences between the measured BOLD and P et CO 2 wave forms were corrected, and the CVR (% BOLD signal change/mmHg CO 2 ) was computed in MATLAB using the robust linear least squares fit to the correlation between the two time courses.
Statistical analysis
SAS Software Package (Version 9Á4; SAS Inc., Cary, NC) was used for statistical analysis. Demographic characteristics are expressed as mean AE standard deviation (SD). A paired t-test was used to compare baseline PCO 2 levels between visit one and visit two. An a value of 0Á05 was used to signify statistical significance for t-test measures. Square-specific characteristics (P et O 2 , BOLD CVR, CVR standard deviation (dCVR) and R 2 ) are expressed as mean AE standard error of the mean (SEM). An independent sample t-test was used to determine whether average P et O 2 values were iso-oxic at 100 mmHg. Test-retest reproducibility of CVR was performed both within visits and between visits using a two-way agreement intraclass correlation coefficient (ICC, or coefficient of reliability), as well as coefficient of within-subject variation (CV), for squares one and two at each visit. Bland-Altman analyses were also performed. GraphPad Prism Software (Prism version 6Á0, GraphPad Software, Inc., La Jolla, CA) was used to create Bland-Altman analysis plots.
Within-visit ICC and CV comparisons were made between MRI scans one and two for each square separately, and between-visit ICC and CV comparisons were made between similar square measurements for each scan separately. Individual ICC and CV comparisons were also made between square one and square two for each visit and scan (i.e. within-scan), separately.
Results
Subject mean age was 26Á5 AE 5Á7 years (males: 30Á4 AE 5Á8 years, females: 23Á2 AE 3Á1 years). Subject-specific baseline P et CO 2 levels were not statistically different between visit one and visit two (31Á2 AE 0Á8 versus 31Á8 AE 1Á1 mmHg, P = 0Á504), respectively. Additionally, subject-specific average P et O 2 levels were not statistically different between visit one and visit two (102Á9 AE 2Á9 versus 101Á1 AE 3Á3 mmHg, P = 0Á07), respectively.
Average BOLD CVR was 0Á43 and .42% BOLD signal change/mmHg CO 2 on visits one and two, respectively. Independent t-tests showed CVR values were not significantly different between squares, scans or days (P>0Á50 for all tests). Test-retest reproducibility (ICC) and CV of CVR for within scan were excellent and between visits were good. These results as well as visual representation of the study protocol format are displayed in Fig. 1 . The Bland-Altman plots (Fig. 2) display good agreement between-and within-day CVR in our study population.
Discussion
The objective of this study was to examine the reproducibility of grey matter CVR using a 10-mmHg square wave change in P et CO 2 . In addition, we examined the repeatability of this 10 mmHg square wave change in P et CO 2 . This study demonstrated that BOLD signal changes in response to alterations in P et CO 2 are reproducible both within-and between-visit MRI scans.
Square waves similar to our protocol are commonly used in CVR studies (Mark et al., 2010; Mutch et al., 2012) . In the present study, we observed good CVR reproducibility using back-to-back square waves that increase P et CO 2 by 10 mmHg which indicates using the proposed breathing technology and BOLD imaging is a reliable method in CVR assessment and may be useful not only in interventionbased studies but also in case-control comparisons and clinical applications.
In the present study, CVR within-scan reproducibility was very good (average ICC = 0Á84). The differences in CVR measurements were less than 6Á75% in all within-scan trials (average CV = 5Á70%). The between-scan reproducibility (e.g. square 1/scan 1 versus square 1/scan 2) was also very good to excellent (average ICC = 0Á81, CV = 6Á83%). Based on these data, we conclude within-visit CVR using this method is reproducible. CVR reproducibility between visit one and visit two (separated by at least 3 days) was good (average ICC = 0Á69, CV = 7Á87). The slightly lower between-visit reproducibility may reflect normal variation in day-to-day physiologic difference within subjects; however, these values are still very reproducible. These results suggest that high degree of reproducibility in measuring CVR using the techniques employed in the current study.
To our knowledge, only one other study specifically investigated the within-and between-day reproducibility of BOLD CVR measures using rapid changes in P et CO 2 (Kassner et al., 2010) . It should be noted that Kassner et al. (2010) used different techniques from the current study (8-to 45-s. duration,~15 mmHg increases in CO 2 ); however, the reproducibility within grey matter was similar to our results. It should be noted that the mean CVR value (0Á162 AE 0Á007%) reported in the study by Kassner et al. (2010) was lower than what we observed in the present study (0Á421 AE 0Á006%). The differences in CVR values from our study and those of Kassner et al. (2010) may be due in part to the differences in MRI field strength (1Á5T versus 3Á0T). In addition, it should be pointed that Kassner et al. (2010) did not clamp the P et O 2 levels during the study, which may have also contributed to the lower measured CVR (Mark et al., 2010) . In the present study, we eliminated the possible effect of alterations in P et O 2 levels on CVR values by clamping P et O 2 .
There are some limitations to the present study. It has been suggested that over the entire physiologic range, BOLD CVR follows a sigmoidal relationship (Sobczyk et al., 2014) . However, in this experiment, the range increase from each subject's baseline P et CO 2 may be assumed to be within the linear portion of this relationship although this was not shown empirically in this experiment.
In conclusion, CVR measured using two consecutive square waves (+10 mmHg P et CO 2 from baseline) using controlled iso-oxic hypercapnic stimuli is very reproducible both within and between visits. This establishes an accurate method for measuring CVR in individuals that may be used not only in the comparison between various groups of individuals but also in longitudinal studies interested in treatment or examination of CVR over time (i.e., ageing studies, traumatic brain injury evaluation).
